Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

NAActive, not recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

May 7, 2025

Study Completion Date

August 31, 2025

Conditions
Atrial Fibrillation
Interventions
DEVICE

Catheter Ablation

Cardiac catheter ablation for recurrent AF after previous ablation (catheter or surgical).

Trial Locations (19)

9300

OLV Aalst, Aalst

11030

Northwell Health System, New York

15212

Allegheny Health Network, Pittsburgh

19104

Penn Presbyterian Medical Center, Philadelphia

22042

Inova Fairfax Hospital, Fairfax

31076

Clinique Pasteur, Toulouse

32204

Ascension St. Vincent's Hospital, Jacksonville

35243

Grandview Medical Center, Birmingham

43210

The Ohio State University, Columbus

60152

Loyola University, Maywood

60201

Northshore University Health System, Evanston

60208

Northwestern University, Evanston

63130

Washington University, St Louis

66211

Kansas City Cardiac Arrhythmia Research LLC, Overland Park

72401

Arrhythmia Research Group, Jonesboro

77030

Houston Methodist Research Institute, Houston

80636

Deutsches Herzzentrum München, München

91300

Hôpital Privé Jacques Cartier, Massy

02241

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Volta Medical

INDUSTRY